Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Safety clinical trials
Every US clinical trial registered for Safety — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
11 US clinical trials · 3 currently recruiting
The research picture
Safety has 11 registered US clinical trials, 3 of them open to new participants right now — about 27% of the total.
- 3
- recruiting participants now
- 27%
- of trials open to enrollment
- 2
- in Phase 3–4 (later-stage)
- 1
- top sponsor: Altasciences Company
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
Curcumin and Retinal Study
Texas Tech University Health Sciences Center
NCT05774704
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
Basilea Pharmaceutica
NCT06733675
PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study
ARJ Medical
NCT05276557
Prospective G7 Dual Mobility Total Hip PMCF
Zimmer Biomet
NCT03308929
Developing a Dyadic Shared Decision Making Tool About Firearm Storage
Seattle Children's Hospital
NCT05451355
Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects
Actelion
NCT02206204
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
Novartis Pharmaceuticals
NCT01576666
Simultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy Study
Duke University
NCT06503900
Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid Experience
Altasciences Company
NCT06072170
Safety and Tolerability of a Novel Amino-acid Based Hydration Drink in Healthy Volunteers
University of Memphis
NCT05592951
Study to Assess the Safety and the Phosphate Binding Capacity of Renazorb
Spectrum Pharmaceuticals
NCT01560884
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Safety Trial Landscape
ClinicalTrials.gov lists 11 US studies indexed under Safety, and 3 of those are currently open to recruitment — roughly 27% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Safety shows 2 late-stage studies (Phase 3 and Phase 4 combined) alongside 6 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Safety is led by Altasciences Company with 1 indexed trial, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 11 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Safety?
PlainTrial tracks 11 US clinical trials for Safety, of which 3 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Safety?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.